- Home
- PRFX vs SNES Comparison
PRFX vs SNES Comparison
Compare PRFX & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRFX
- SNES
- Stock Information
- Founded
- PRFX 2007
- SNES 2004
- Country
- PRFX Israel
- SNES United States
- Employees
- PRFX N/A
- SNES N/A
- Industry
- PRFX Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- PRFX Health Care
- SNES Industrials
- Exchange
- PRFX Nasdaq
- SNES Nasdaq
- Market Cap
- PRFX 1.6M
- SNES 1.6M
- IPO Year
- PRFX 2020
- SNES 2016
- Fundamental
- Price
- PRFX $0.62
- SNES $2.94
- Analyst Decision
- PRFX Strong Buy
- SNES Strong Buy
- Analyst Count
- PRFX 1
- SNES 1
- Target Price
- PRFX $12.00
- SNES $35.00
- AVG Volume (30 Days)
- PRFX 238.9K
- SNES 58.1K
- Earning Date
- PRFX 11-13-2024
- SNES 11-07-2024
- Dividend Yield
- PRFX N/A
- SNES N/A
- EPS Growth
- PRFX N/A
- SNES N/A
- EPS
- PRFX N/A
- SNES N/A
- Revenue
- PRFX N/A
- SNES $1,529,000.00
- Revenue This Year
- PRFX N/A
- SNES $91.45
- Revenue Next Year
- PRFX N/A
- SNES $101.31
- P/E Ratio
- PRFX N/A
- SNES N/A
- Revenue Growth
- PRFX N/A
- SNES 40.92
- 52 Week Low
- PRFX $0.53
- SNES $1.90
- 52 Week High
- PRFX $20.16
- SNES $48.60
- Technical
- Relative Strength Index (RSI)
- PRFX 37.34
- SNES 57.45
- Support Level
- PRFX $0.53
- SNES $2.18
- Resistance Level
- PRFX $0.79
- SNES $2.36
- Average True Range (ATR)
- PRFX 0.06
- SNES 0.26
- MACD
- PRFX 0.04
- SNES 0.09
- Stochastic Oscillator
- PRFX 35.06
- SNES 86.80
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.